Friday, January 12, 2018 10:15 PM ET
Biohaven Pharmaceutical Holding (BHVN) sees Significant Insider Sales Extending the Trend of Last Quarter
There was a substantial level of insider selling disclosed today in filings with the SEC for Biohaven Pharmaceutical Holding. Two insiders — Declan Doogan, Director, and Dr Robert Berman, Officer — sold 156,942 shares in the company for approximately $4,228,670. There have been 4 insiders with buy/sell transactions in the past 90 days prior to these filings. All of these trades have been sales resulting in the sale of 559,481 company shares. Adding the most recent activity to this 90-day history indicates insider trades have seen net sales of 716,423 shares and have averaged 119,404 shares per transaction over this time period.
The number of insider buy/sell trades at Biohaven Pharmaceutical Holding is greater than that of the 191 peer company average over the last 90-day period. The Biotechnology & Medical Research peer group saw 161 buy/sell trades during this period for an average of 0.8 transactions per company. However, the number of shares traded per transaction by Biohaven Pharmaceutical Holding insiders is lower than its peers. Within the peer group there were 26,450,995 shares purchased and 11,109,668 shares sold with company insiders acquiring 132,253 shares on average over this time period.
In determining significant insider buying and selling, trades reported to the SEC that involve awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers have been eliminated in data used to evaluate and write this story.
Today’s Insider Activity
* Declan Doogan, Director, sold 121,942 shares
* Dr Robert Berman, Officer, sold 35,000 shares
Using proprietary Natural Language Generation (NLG) technology, UpTick evaluates corporate insider filings reported to the SEC and creates real-time news and analysis to report the most significant insider transactions based on transaction type, size and historical trends.
For more information, contact UpTick at email@example.com. Copyright 2018 UpTick Data Technologies. All rights reserved.